821
Participants
Start Date
December 31, 2003
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
Donepezil Hydrochloride
Subects will receive a starting dose of 5 mg orally. Dose-escalation from 5 mg to 10 mg will occur at the Week 9 Visit.
Placebo
Subjects will receive matching placebo tablets.
Albaster
Mesa
Peoria
Sun City
Tucson
Fresno
Garden Grove
Irvine
San Francisco
Denver
New Haven
Boynton Beach
Fort Meyers
Hollywood
Jacksonville
Melbourne
North Miami
Ocala
Sarasota
St. Petersburg
Tampa
Venice
West Palm Beach
Snellville
Chicago
Elkhart
New Orleans
Farmington Hills
Kalamazoo
Las Vegas
Kenilworth
Long Branch
Albany
Lexington
New York
Rochester
Staten Island
No. Charleston
Centerville
Cleveland
Toledo
Medford
Portland
Greensberg
Pittsburgh
Providence
Madison
Houston
San Antonio
Wichita Falls
Salt Lake City
Bennington
Charlottesville
Seattle
Collaborators (1)
Pfizer
INDUSTRY
Eisai Inc.
INDUSTRY